✦ LIBER ✦

Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial

✍ Scribed by Richmond, Peter C; Marshall, Helen S; Nissen, Michael D; Jiang, Qin; Jansen, Kathrin U; Garcés-Sánchez, Maria; Martinón-Torres, Federico; Beeslaar, Johannes; Szenborn, Leszek; Wysocki, Jacek

Book ID: 123553583
Publisher: The Lancet
Year: 2012
Tongue: English
Weight: 293 KB
Volume: 12
Category: Article
ISSN: 1473-3099
DOI: 10.1016/S1473-3099(12)70087-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized, phase 1/2 trial of the saf

A randomized, phase 1/2 trial of the safety, tolerability, and immunogenicity of bivalent rLP2086 meningococcal B vaccine in healthy infants

✍ Martinon-Torres, Federico; Gimenez-Sanchez, Francisco; Bernaola-Iturbe, Enrique; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 651 KB

Immunogenicity and tolerability of a mul

Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study

✍ María Elena Santolaya; Miguel L O'Ryan; María Teresa Valenzuela; Valeria Prado; 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 265 KB

Immunogenicity and safety of an enterovi

Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: a randomised, double-blind, placebo-controlled phase 2 clinical trial

✍ Zhu, Feng-Cai; Liang, Zheng-Lun; Li, Xiu-Ling; Ge, Heng-Ming; Meng, Fan-Yue; Mao 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 166 KB